Qiaxuan Li

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma

Haiyu Zhou, Yong Zheng, F. Zeng, 2022, Frontiers in Immunology.

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer

Haiyu Zhou, Shaowei Wu, D. Xie, 2021, Frontiers in Oncology.

Exenatide enhanced the antitumor efficacy on PD-1 blockade by the attenuation of neutrophil extracellular traps.

Haiyu Zhou, Xiang Zheng, Luyu Huang, 2022, Biochemical and biophysical research communications.

A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy

Haiyu Zhou, Ziyang Cao, Yucheng Huang, 2023, Bioactive materials.

Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study

M. Lanuti, Siyun Wang, Bin Xu, 2023, Journal for ImmunoTherapy of Cancer.